CVE-2015-3952
No exploitation reported by the sources we read.
- Published2019-03-25
- WeaknessCWE-200 · CWE-312
Am I affected?
Debian, Ubuntu or Red Hat sometimes backport a fix without changing the upstream version number: such a version reads « to verify », never « affected ».With a domain, we read the version its public headers and pages expose. A distribution build can carry the fix under an older number.
Description
Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
Timeline
dates in UTC- 2019-03-2516:29CVE publishedNVD
Observed activity
isMalicious corpus · updated 2026-10-23 18:48 UTCBlock these indicators
- Firewall list (EDL, text): https://api.ismalicious.com/edl/cve/CVE-2015-3952?format=txt
- CSV export: https://api.ismalicious.com/edl/cve/CVE-2015-3952?format=csv
- TAXII collection of exploited CVEs
- The EDL and CSV take an API key on the Pro plan.
Versions per branch
NVD| Branch | Affected | Fixed in | Source |
|---|---|---|---|
| 13.4 | ≤ 13.4 | no fix published | NVD |
| Branch | Affected | Fixed in | Source |
|---|---|---|---|
| 13.6 | ≤ 13.6 | no fix published | NVD |
| Branch | Affected | Fixed in | Source |
|---|---|---|---|
| 3.13 | ≤ 3.13 | no fix published | NVD |
as publishedRanges as NVD and OSV publish them; a distribution’s build can be fixed under an older number.
Distribution builds and vendor advisories
Packages from OSV.dev and products from the vendors' CSAF advisories.
version not verifiedVersions not verified: read as OSV.dev and the vendors publish them, not checked against each vendor's release list.
Vendor advisories
Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities
Hospira Plum A+ Infusion System: <=13.4 · Hospira Plum A+3 Infusion System: <=13.6 · Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015…
Fix
- Mitigation from the vendor CISA ICSA-15-161-01 · 3 productsHospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vu…
- Mitigation from the vendor CISA ICSA-15-161-01 · 3 productsFor additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
Advisories and patches
- ics-cert.us-cert.govMitigation
Detection
- Nuclei template
- none so far ProjectDiscovery
- Exploit-DB
- no entry Exploit-DB
- Proof-of-concept repositories
- none listed PoC-in-GitHub
Sources
- NVDCVSS 3.07.5read 2026-10-23
- NVDCVSS 2.05read 2026-10-23
- CNAweakness (CWE)CWE-312read 2026-10-23
- NVDweakness (CWE)CWE-200read 2026-10-23
- FIRST EPSSEPSS score1.0 %2026-10-22
Technical details
- CVSS v3 Vector
- CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- Published
- 2019-03-25
- Last Modified
- 2026-06-17
- NVD status
- Modified
Frequently asked questions
What is CVE-2015-3952?
Is CVE-2015-3952 actively exploited?
What is the CVSS score for CVE-2015-3952?
Hear about the next vulnerability in your software
Surveillance reads the versions in your stack — a domain, a lockfile or a list — checks each CVE against the ranges its sources publish, and alerts you when one you run is exploited or enters CISA KEV. A version it cannot read stays « version not verified ».
No credit card required · No monthly cap on website lookups · 250 API requests/month
Go further
- Following what attackers exploit right now? The CISA KEV additions of the month, with their patch deadlines.
- Running this software? Vulnerability monitoring alerts you to new vulnerabilities in your products.
Related vulnerabilities
Same product first, then the same vendor advisory and the same publication week.